⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001851895

Thompson Alexis A.

Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA

Transactions

16

Companies

1

Filings

5

CIK

0001851895

Forms 4 and 5

Insider transactions

16 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-10-05	Global Blood Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−3,308 sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−4,800 sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−3,600 sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11.2K sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,412 sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,600 sh	—	—	0
2022-06-14	Global Blood Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+908 sh	—	—	3,308
2022-06-14	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−908 sh	—	—	0
2022-06-14	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+5,600 sh	—	—	5,600
2022-06-14	Global Blood Therapeutics, Inc.Restricted Stock UnitsA Award	Director	AAward	+3,600 sh	—	—	3,600
2022-03-17	Global Blood Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,400 sh	—	—	2,400
2022-03-17	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,400 sh	—	—	4,800
2021-06-17	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+1,412 sh	—	—	1,412
2021-06-17	Global Blood Therapeutics, Inc.Restricted Stock UnitsA Award	Director	AAward	+908 sh	—	—	908
2021-03-17	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+11.2K sh	—	—	11,200
2021-03-17	Global Blood Therapeutics, Inc.Restricted Stock UnitsA Award	Director	AAward	+7,200 sh	—	—	7,200

Recent filings

5

Accepted (ET)
Oct 64
Thompson Alexis A.0000899243-22-033160
SEC(opens sec.gov)
Jun 164
Thompson Alexis A.0000899243-22-022891
SEC(opens sec.gov)
Mar 184
Thompson Alexis A.0000899243-22-011617
SEC(opens sec.gov)
Jun 214
Thompson Alexis A.0000899243-21-024978
SEC(opens sec.gov)
Mar 194
Thompson Alexis A.0000899243-21-012738
SEC(opens sec.gov)

Companies

1

Global Blood Therapeutics, Inc.Director

Address

C/O GLOBAL BLOOD THERAPEUTICS, INC. 181 OYSTER POINT BLVD.

SOUTH SAN FRANCISCO, CA, 94080